Drug Topics
OCTOBER 27, 2023
The awards recognize the teams, coaches, and pharmacies that have demonstrated outstanding commitment to transforming community pharmacy practice.
PharmaVoice
OCTOBER 27, 2023
This year's inductees to the PharmaVoice 100 "hall of fame" are leaders who have been at the forefront — and will stay at the forefront — of industry change.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 27, 2023
Patients who were bedridden for 7 days or longer had the highest prevalence of symptoms, which included fatigue, shortness of breath, chest pain, dizziness, and trouble sleeping.
PharmaVoice
OCTOBER 27, 2023
Ken Getz has spent his career improving clinical research for the benefit of patients, the life sciences industry and other R&D stakeholders.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 27, 2023
A new study adds to previous research that has found religious and political correlations between vaccine beliefs and hesitancy, which have geographical links.
PharmaVoice
OCTOBER 27, 2023
Precigen’s CEO is pushing for her next therapeutic breakthrough with innovative cell and gene therapy platforms.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
OCTOBER 27, 2023
A consummate life sciences executive who has led with boldness and devotion, Dr. Jeremy Levin considers himself a participant as well as a leader.
Drug Topics
OCTOBER 27, 2023
The CPESN Outstanding Network Facilitator Award is sponsored by Compliant Pharmacy Alliance.
Pharmacy Times
OCTOBER 27, 2023
Pharmacists’ pharmacotherapeutic expertise helps them advocate for their patients and assist providers.
Drug Topics
OCTOBER 27, 2023
The first part of the series features HCP education on key facts about vaccine hesitancy. A simulated pharmacist/patient encounter is also included which highlights key methods for HCPs to get patients to overcome vaccine hesitancy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 27, 2023
Mirikizumab-mrkz (Omvoh; Eli Lilly and Company) is the first IL-23p19 antagonist approved for adult patients with moderately to severely active ulcerative colitis.
Drug Topics
OCTOBER 27, 2023
The second part of the series features HCP education on high-risk patients for COVID-19 complications. A simulated pharmacist/patient encounter is also included which highlights best practices for HCPs to communicate with high-risk patients for COVID-19.
PharmaVoice
OCTOBER 27, 2023
Dr. Mark Goldberg has continually been at the cutting edge of technologies and ideas, including now as chairman and CEO of Allucent.
Drug Topics
OCTOBER 27, 2023
The third part of the series features HCP education on key updates in the management of COVID-19. A simulated pharmacist/patient encounter is also included which highlights best practices for incorporating FDA and CDC recommendations for patients with COVID-19.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
OCTOBER 27, 2023
A critical aspect of National Prescription Drug Take Back Day is the focus on Naloxone training.
Drug Topics
OCTOBER 27, 2023
Some factors that influence the inequities in cancer care include historical, structural, systemic, and interpersonal factors.
STAT
OCTOBER 27, 2023
Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys. The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases. “I think the big celebration here is we’re showing, in primates, for the company, that we have a delivery system that is working and is safe,” said J
Drug Topics
OCTOBER 27, 2023
Future disease-modifying interventions for COPD may greatly affect quality of life and survival.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
OCTOBER 27, 2023
Arexvy shows efficacy in helping protect adults aged 50 to 59 years with an increased risk for respiratory syncytial virus lower respiratory tract disease.
STAT
OCTOBER 27, 2023
The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA. None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.
Pharmacy Times
OCTOBER 27, 2023
With a new administration protocol created specifically for the routine clinic, infectious disease physicians can treat recurrent clostridioides difficile infection in less than 3 weeks.
Fierce Healthcare
OCTOBER 27, 2023
Older adults are adopting digital health tools at a higher rate than ever before. | At Elevance Health, we are seeing an increasing acceptance of virtual care and technology by older adults to help manage their health.
STAT
OCTOBER 27, 2023
While much of the health care workforce is battling staff shortages, the emergency medicine field is trying to figure out how to manage a potential oversupply of physicians. The American College of Emergency Physicians predicted in a 2021 study that there would be a surplus of nearly 8,000 emergency physicians by 2030.
Drug Store News
OCTOBER 27, 2023
Sheryl Burke, SVP of Corporate Social Responsibility & Chief Sustainability Officer of CVS Health, shines a light on the retailer's efforts to help communities at the local and national levels.
STAT
OCTOBER 27, 2023
WASHINGTON — The Senate Finance Committee plans to vote Nov. 8 on legislation that includes substance abuse and mental health policies, reforms to drug middlemen’s business practices, and extensions to provider payment policies in Medicare and Medicaid, according to five health care lobbyists. The legislation would package together versions of health care policies that the committee has been working on for some time.
Fierce Healthcare
OCTOBER 27, 2023
The federal government is rolling back a pandemic-era waiver that lowered the bar for 340B hospitals to dispense discounted drugs across additional outpatient sites, a decision hospitals said will | HRSA is giving hospitals 90 days to bring any off-site, outpatient facilities using 340B drugs into compliance with requirements that had been waived during the COVID-19 pandemic.
PharmaVoice
OCTOBER 27, 2023
With a knack for melding science and patient-focused marketing techniques, the CEO of the biopharma commercial unit at Sumitomo Pharma America has notched blockbuster successes throughout her career.
Fierce Healthcare
OCTOBER 27, 2023
Bright Health Group and Friday Health Plans are both unable to pay their dues into the 2022 Affordable Care Act risk adjustment pool, costing their peers more than $1 billion, according to a notice | Bright Health Group and Friday Health Plans are both unable to pay their dues into the 2022 Affordable Care Act risk adjustment pool, CMS said.
Pharmacy Times
OCTOBER 27, 2023
Faricimab is the first and only bispecific antibody granted FDA approval for treatment of the eye.
Fierce Healthcare
OCTOBER 27, 2023
SingFit, a therapeutic music health platform for people struggling with cognitive and mental health conditions such as Alzheimer’s disease, will now be provided under Longevity Health Plan’s instit | Deemed a significant advancement for music as medicine treatment, a new partnership will provide members in skilled nursing facilities with access to therapeutic health platform SingFit.
Pharmacy Times
OCTOBER 27, 2023
Although everyone’s residency looks different, it is important for mothers to assess childcare options, be transparent about their schedule, and take care of themselves.
Fierce Healthcare
OCTOBER 27, 2023
The Department of Justice (DOJ) has filed charges against a former HealthSun Health Plans executive as part of an alleged multimillion-dollar Medicare fraud scheme. | The Department of Justice has filed charges against a former HealthSun Health Plans executive as part of an alleged multimillion-dollar Medicare fraud scheme.
STAT
OCTOBER 27, 2023
Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu. Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading.
Expert insights. Personalized for you.
503 
Let's personalize your content